TICKERNERD
Menu
CCCCBasic Materials · Specialty Chemicals

CC Stock Forecast: The Chemours Co. Price Predictions for 2026-2027

Last close, 13 Nov 2026
$13
−0.45% on the day

The 10 Wall Street analysts covering The Chemours Co. hold a median 12-month price target of $16 — +16.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 57 of 100 as at 13 Nov 2026 — in the upper half.

Market cap
$2.0B
Ticker Nerd rank
57/ 100
Median analyst target
$16
Analysts covering
10
Revenue$1.6B−1.5% y/y
Operating income−$210.0M
Net income−$274.0M
Free cash flow$114.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+4.2%
1M
+0.7%
YTD
+14.4%
1Y
+10.7%
From 52W high
−52.0%
From 52W low
+28.6%
$10
$28
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores The Chemours Co. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Nov 2026
57/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
87
Accruals
86
Value
85
Momentum
46
Growth
42
Quality
42
Volatility
36
Size
35
Revisions
32

Issuance (87): The share count has been shrinking and the company is not leaning on new borrowing.

Revisions (32): Analysts have, on balance, been cutting their forecasts.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20$25$30Jan 26Apr 26Jul 26Oct 26CCHigh $18Median $16Low $14

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says10 analysts
2 Buy8 Hold0 Sell
Low $14Median $16High $18

The green dot is the last close — the median target sits +16.6% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 0 moved their price target up and 11 moved it down.

DateFirmActionRatingTarget
9 Nov 2026JP MorganMaintainsNeutral$15 → $14
4 Nov 2026Truist SecuritiesMaintainsBuy$20 → $18
4 Nov 2026UBSMaintainsNeutral$16 → $15
20 Oct 2026Truist SecuritiesMaintainsBuy—
20 Oct 2026Truist SecuritiesMaintainsBuy$24 → $20
14 Oct 2026MizuhoDowngradeNeutral$18 → $15
14 Oct 2026MizuhoDowngradeNeutral—
13 Oct 2026BarclaysInitiatesEqual-Weight$16
13 Oct 2026BarclaysInitiatesEqual-Weight—
5 Oct 2026UBSMaintainsNeutral$18 → $16
5 Oct 2026UBSMaintainsNeutral—
30 Sept 2026MizuhoMaintainsOutperform—
30 Sept 2026MizuhoMaintainsOutperform$20 → $18
13 Aug 2026BMO CapitalMaintainsOutperform$26 → $18
13 Aug 2026BMO CapitalMaintainsOutperform—
13 Aug 2026JP MorganMaintainsNeutral$22 → $15
13 Aug 2026JP MorganMaintainsNeutral—
10 Aug 2026UBSDowngradeNeutral—
10 Aug 2026UBSDowngradeNeutral$29 → $18
6 Aug 2026RBC CapitalMaintainsOutperform$26 → $22

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CC appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

CC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 13 Nov 2026, The Chemours Co. returned +10.7% against +13.4% for the S&P 500, dividends included.

CC vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200Jan 26Apr 26Jul 26Oct 26CCS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
−6.9%
Analysts raising
0
Analysts cutting
4
Fundamentals

The Chemours Co. (CC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
67.8×

Cheaper than 10% of US stocks

Price / sales
0.3×

Cheaper than 86% of US stocks

Price / book
12.9×

Cheaper than 7% of US stocks

EV / EBITDA
11.1×

Cheaper than 34% of US stocks

Growth & margins
Revenue growth (YoY)
3.0%

Higher than 35% of US stocks

Earnings growth (YoY)
326.1%

Higher than 93% of US stocks

Gross margin
18.0%

Higher than 18% of US stocks

Operating margin
2.9%

Higher than 51% of US stocks

Net margin
−2.6%

Higher than 26% of US stocks

Returns & dividend
Return on equity
−68.0%

Higher than 18% of US stocks

Return on assets
1.4%

Higher than 54% of US stocks

Dividend yield
2.6%

Higher than 84% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

The Chemours Co. (CC) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • The Chemours Co. has a market value of $2.0B and an enterprise value of $5.4B.

  • Revenue in the twelve months to 30 June 2026: $5.8B. The latest quarter grew 3.0% year on year.

  • Net income over the same four quarters: −$305.0M, a −5.3% net margin.

  • Free cash flow in the twelve months to 30 June 2026: $218.0M.

  • The Chemours Co. spent $54.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 150.5M.

  • Trailing P/E: 67.8×; forward P/E: 7.7× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.65%, paying out 1667% of earnings.

  • The Chemours Co. employs 5,700 people — $1.0M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Nov 2026

Data provided by Twelve Data

Peers

CC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
CCThe Chemours Co.$2.0B57
IOSPInnospec, Inc.$2.0B88
MTXMinerals Technologies, Inc.$1.9B57
NGVTIngevity Corp.$2.1B94
SCLStepan Co.$1.5B90
FULH.B. Fuller Co.$2.7B76
KWRQuaker Houghton$2.7B76

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own The Chemours Co. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CC news & analysis

Kaplan Fox Notifies Investors of The Chemours Company (CC) of the Lead Plaintiff Deadline on December 7, 2026

Newsfile Corp · 13 Nov 2026negative

Kaplan Fox & Kilsheimer LLP announced that a class action lawsuit has been filed against The Chemours Company on behalf of investors who acquired its securities between February 20 and August 4, 2026. The firm noted that the lead plaintiff deadline is December 7, 2026.

Why it matters — The lawsuit and lead plaintiff deadline are developments concerning Chemours and investors who acquired its securities during the stated period.

CC INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges The Chemours Company Investors to Contact the Firm Before December 7th Seeking Lead Plaintiff Role

GlobeNewsWire · 12 Nov 2026negative

Bragar Eagel & Squire urged Chemours investors who suffered losses to contact the firm to discuss their options. The headline says investors have until December 7 to seek a lead plaintiff role.

Why it matters — The notice concerns potential investor litigation involving Chemours and may be relevant to shareholders following the matter.

FAQ

Frequently asked questions about CC stock

What is the CC stock price forecast for 2026-2027?

The 10 Wall Street analysts covering The Chemours Co. have a median 12-month price target of $16, with estimates ranging from $14 to $18. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CC stock a buy right now?

Of the 10 analysts covering The Chemours Co., 2 rate it a Buy, 8 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Chemours Co. 57 out of 100 across roughly 4,600 US stocks as at 13 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CC?

As at 13 Nov 2026, The Chemours Co. ranks 57 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (87 of 100).

Will CC stock go up?

No one can know that. What the data says: the median 12-month target from 10 analysts implies +16.6% from the last close, and Ticker Nerd's factor model ranks The Chemours Co. 57 out of 100 as at 13 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CC stock forecast for 2030?

No analyst covering The Chemours Co. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $14 to $18 over the next 12 months.

How has CC stock performed over the past year?

The Chemours Co. returned +10.7% over the 12 months to 13 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does The Chemours Co. do?

The Chemours Company is a global chemistry company that develops and supplies industrial and specialty chemical products for a wide range of end markets. Its core business is organized into Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, each serving distinct applications across refrigeration and air conditioning, coatings, plastics, transportation, semiconductors, electronics, and general industrial uses.

What is the latest news on CC?

The most recent item we track (Newsfile Corp, 13 Nov 2026): "Kaplan Fox Notifies Investors of The Chemours Company (CC) of the Lead Plaintiff Deadline on December 7, 2026". Kaplan Fox & Kilsheimer LLP announced that a class action lawsuit has been filed against The Chemours Company on behalf of investors who acquired its securities between February 20 and August 4, 2026. The firm noted that the lead plaintiff deadline is December 7, 2026.

Company

About The Chemours Co.

The Chemours Company is a global chemistry company that develops and supplies industrial and specialty chemical products for a wide range of end markets. Its core business is organized into Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, each serving distinct applications across refrigeration and air conditioning, coatings, plastics, transportation, semiconductors, electronics, and general industrial uses. The company’s product portfolio includes refrigerants, thermal management solutions, propellants, blowing agents, specialty solvents, titanium dioxide pigments, and advanced fluoropolymer materials. These materials are used as key inputs in manufacturing and performance-driven applications, supporting customers that need durability, efficiency, brightness, opacity, and thermal control. Chemours serves a global customer base across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, making it an important supplier within the specialty chemicals market.

CEO Ms. Denise M. Dignam · 5,700 employees · United States · https://www.chemours.com